06.09.2009

Free Webinar Course on Researcher Commercialization
This highly successful online webinar course had 2,600 attendees the last time it was offered in January. It is recommended for researchers in research institutions (e.g., grad students, post-docs, professional staff and faculty) and researchers in commercial companies (e.g., startups, SBIRs, research-based small businesses and Global 1000). It allows attendees to make an informed decision as to how to better plan their commercialization efforts, be it through employment, licensing, consulting, joint venturing or startup creation.

06.09.2009: 

LaamScience Raises $2.5M  

The next key step for NC State startup, LaamScience, is clearance from the U.S. Food and Drug Administration for its antibacterial and antiviral textile coating.

06.08.2009: 

NC IDEA Announces Spring Grant Recipients: Tec-Cel  

NC State's Tec-Cel is commercializing next-generation lithium-ion batteries that have a theoretical storage capacity of greater than 10 fold capacity increase over current graphite anodes.

05.26.2009: 

Galaxy Diagnostics Plans to Fight Bug Borne Bacteria 

NC State startup, Galaxy, is developing a diagnostic for Bartonella bacteria.

05.10.2009:

ZettaCore Raises $21 Million in Series C Round  

NC State startup, ZettaCore, a developer of molecular materials and technology for next-generation semiconductor products, will use the funding to bring its technology to market.

04.06.2009

BioMarck Pharmaceuticals Closes $6.3M Series C Financing Round
BioMarck, an NC State company involved in the treatment of respiratory diseases, has closed on a financing round for over $6.3 million. The company has also received a grant of $990,000 from the National Institute of Health.

03.11.2009

03.10.2009

03.09.2009

Washington Post:  Scientists Target Bacteria Where They Live
At North Carolina State University in Raleigh, two chemistry professors say they might have found a potential key to biofilm dispersion in the oceans, which scientists are mining for a variety of new drugs.

02.02.2009

BioMarck receives $990,000 NHI grant
BioMarck Pharmaceuticals, an NC State startup, receives grant funding from the National Heart, Lung and Blood Institute.

01.07.2009

Liquidia, Abbott Team Up to Target Cancer
Liquidia Technologies, an NC State/UNC Chapel Hill startup, announces partnership with Abbot Laboratories to refine cancer treatment.

01.05.2009

Trana Discovery Offers New Approach to Fighting Infectious Disease
Trana Discovery, a biotech startup out of North Carolina State University and the Technical University of Lodz, Poland, has developed a new patented technology that may help defeat a wide range of infectious diseases, including antibiotic resistant staph and the AIDS virus.

10.08.2008

Trana Discovery Awarded $250,000 Loan by the North Carolina Biotechnology Center
Trana Discovery, Inc., an NC State drug discovery technology company, announces plans for the development and commercialization of a new High-Throughput Screening (HTS) assay capable of identifying compounds that inhibit the reproduction of Staphylococcus aureus bacteria.

10.06.2008

Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C

Biolex Therapeutics, Inc. announced the closing of a $60 million Series D financing led by Clarus Ventures, a leading biotechnology investor, with OrbiMed Advisors participating as a new investor.

8.25.2008

Hydrogen-Producing Bacteria Provide Clean Energy

A new "green" technology developed cooperatively by scientists with the Agricultural Research Service (ARS) and NC State could lead to production of hydrogen from nitrogen-fixing bacteria.

8.15.2008

Sicel Technologies going after $20M in fundraiser

Medical technology company, Sicel Technologies islooking to raise $20 million.  Dr. Charles Scarantino, a radiation oncologist at Rex Hospital, helped develop some of the company’s technology with Troy Nagle, a professor of electrical and computer engineering at North Carolina State University.

8.08.2008

NanoVector virus may solve nanoparticle drug delivery problems

NanoVector is initially targeting cancer therapies but Franzen says that once the company overcomes regulatory issues, the system could be used to administer pain drugs or any other targeted medicines.

8.08.2008

Heat-Loving Bacteria Could Hold Key to Hydrogen as Power Source

A North Carolina State University engineer has been awarded a $1.6 million grant from the U.S. Department of Energy to learn more about the microbiology, genetics and genomics behind how and why heat-loving bacteria called thermotogales produce large amounts of hydrogen with unusually high efficiencies.

8.07.2008
NC State Start-Up, Cree Leads Global LED Market

Founded in Durham in 1987 by N.C. State graduates, Cree is a global market leader in light-emitting diode (LED) lighting, LED components and chips, power switching and wireless communications devices.

5.20.08

Centia(TM) Advanced Biofuels Process Awarded Development Grant from Biofuels Center

Centia(TM), an advanced biofuels conversion technology developed by NC State and licensed to Diversified Energy Corporation, has been awarded a $200k development grant from the Biofuels Center of North Carolina.